bosentan anhydrous has been researched along with Nephrogenic Systemic Fibrosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishikawa, O; Monma, F; Motegi, S; Ogino, S; Okada, E; Suzuki, T; Takeuchi, Y; Uchiyama, A; Yamada, K; Yokoyama, Y | 1 |
1 other study(ies) available for bosentan anhydrous and Nephrogenic Systemic Fibrosis
| Article | Year |
|---|---|
Role of endothelin-1/endothelin receptor signaling in fibrosis and calcification in nephrogenic systemic fibrosis.
Topics: Adolescent; Bosentan; Calcinosis; Cell Proliferation; Cells, Cultured; Contrast Media; Endothelin Receptor Antagonists; Endothelin-1; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Mesenchymal Stem Cells; Middle Aged; Nephrogenic Fibrosing Dermopathy; Receptor, Endothelin A; Signal Transduction; Sulfonamides | 2014 |